Skip to content
Awesome – Lifestyle
Author:
Iterion Therapeutics
Iterion Therapeutics Strengthens Board with Additions of Manuel Aivado, MD, PhD and Bob Smith
August 12, 2026
Iterion Therapeutics Reports First Clinical Validation of Tegavivint as a Targeted Therapy for Wnt-Driven Advanced HCC in Oral Presentation at 2026 ASCO Annual Meeting
June 1, 2026